Alpha2 adrenoceptor agonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9249127
SERIAL NO

14389466

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of formula (I), wherein X and R1-R6, are as defined in the claims, exhibit alpha2 agonistic activity and thus are useful as alpha2 agonists, especially as alpha2A agonists. Methods of use of said compounds are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ORION CORPORATION02200 ESPOO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Koskelainen, Tuula Lohja, FI 3 8
Linnanen, Tero Tuusula, FI 17 66
Mäkelä, Mikko Espoo, FI 16 48
Minkkilä, Anna Turku, FI 1 0
Pohjakallio, Antti Espoo, FI 3 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 2, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00